Beyer, Susanne
Chen, Fangfang
Meister, Sarah
Czogalla, Bastian
Kolben, Theresa M.
Hester, Anna
Burges, Alexander
Trillsch, Fabian
Schmöckel, Elisa
Mayr, Doris
Mayerhofer, Artur
Mahner, Sven
Jeschke, Udo
Kolben, Thomas
Funding for this research was provided by:
German-Israeli Foundation for Scientific Research and Development (GIF I-1417-201.2/2017, GIF I-1417-201.2/2017)
Article History
Accepted: 11 March 2020
First Online: 9 May 2020
Compliance with ethical standards
:
: T.M. Kolben is employed at Roche and holds stock of Roche. A. Burges has received advisory board and honoraria from AstraZeneca, Roche, and Tesaro. F. Trillsch declares Research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Medac, PharmaMar, Roche, Tesaro. S. Mahner has received Research support, advisory board, honoraria and travel expenses from AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro¸ T. Kolben is relative employed at Roche and holds stock of Roche. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethics committee of the LMU Munich (reference number 19-249) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. As all data were anonymized, informed consent was not necessary.